All Articles
Transforming the pharma business model to prevent lost treatment opportunities and optimize return on investment

Transforming the pharma business model to prevent lost treatment opportunities and optimize return on investment

23 May, 2017

Ideally, when diagnostics are used appropriately at specific stages of the patient pathway, patients can receive the right treatment at the right time. However, in the real world clinical setting, achieving synchronization of test and therapy is proving extremely difficult.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.